Sp. Woratyla et al., THE PERFORMANCE OF FEMOROPOPLITEAL BYPASSES USING POLYTETRAFLUOROETHYLENE ABOVE THE KNEE VERSUS AUTOGENOUS VEIN BELOW-THE-KNEE, The American journal of surgery, 174(2), 1997, pp. 169-172
BACKGROUND: Controversy exists as to the choice of conduit for the tre
atment of superficial femoral artery occlusive disease, particularly w
hen a patent above-knee popliteal artery exists. Some surgeons advocat
e the preferential use of polytetrafluoroethylene (PTFE), whereas othe
rs favor the use of autogenous vein. This report compares our experien
ce with above-knee femoropopliteal bypass with PTFE versus below-knee
femoropopliteal bypass with autogenous vein. METHODS: This study cover
s a 15-year period extending from 1982 to 1996 during which 1,313 arte
rial reconstructions were performed for superficial femoral and/or pro
ximal popliteal arterial disease. Four hundred and thirty-eight proced
ures were performed to the above-knee popliteal artery using PTFE, and
875 procedures were performed to the below-knee popliteal artery usin
g autogenous vein. The indication for surgery was limb salvage in 77%
of patients in the PTFE group and 88% of patients in the vein group. R
ESULTS: The 1-, 3-, and 5-year cumulative life table primary patency r
ates for the PTFE group were 74%, 56%, and 50%, respectively. The prim
ary patency rates for the vein bypass group were 83%, 75%, and 67%, re
spectively (P < 0.01). The 5-year cumulative limb salvage rates were 9
1% and 95% for the PTFE and vein groups, respectively (P = NS). CONCLU
SIONS: In this series, below-knee femoropopliteal venous reconstructio
ns have superior patency rates compared with above-knee femoropoplitea
l PTFE reconstructions. Venous reconstruction for femoropopliteal occl
usive disease gives the optimal long-term result. Prosthetic reconstru
ction should be considered for patients with limited venous conduit or
decreased life expectancy. (C) 1997 by Excerpta Medica, Inc.